Agreement gives BIA Separations access to proprietary technology to better preserve integrity, infectivity and potency of immunoaffinity-purified viral vectors for gene therapy Ajdovšcina, Slovenia and Zagreb, Croatia: BIA Separations, a leading bio-chromatography development and manufacturing company, announced it has signed a licensing agreement with the University of Zagreb to commercialize a novel elution method that helps […]
LIVERMORE, Calif.– S2 Genomics, a manufacturer and provider of automated tissue sample preparation systems, and the RIKEN Center for Integrative Medical Sciences (IMS), a leading genomics research institute, today announced that RIKEN IMS has joined the S2 Genomics Early Technology Access Program to evaluate and further develop single cell sequencing applications on the S2 Genomics […]
HELSINKI, Finland – Euformatics partners with bio.logis to enable laboratories using its tertiary analysis platform to provide patients with pharmacogenomic dosing recommendations. While being the topic of countless talks at conferences about personalized medicine for more than a decade, there are encouraging signs, indicating that pharmacogenomic testing is finally finding its way into clinical care. […]
SAN JOSE, Calif. — Thermo Fisher Scientific, the world leader in serving science, and NanoPin Technologies, Inc., the developer of the novel NanoPin diagnostic platform for rapid and quantified results from patient blood samples, have entered into a collaborative relationship to advance blood-based infectious disease detection technology through the development of highly sensitive liquid chromatography mass […]
This Partnership is Based on International Reach, Clinical Utility, Data Generation and Talent Development The University of Melbourne and Illumina, Inc. one of the world’s leading biotech companies, announced a partnership that will enhance Melbourne’s reputation as a world class Biomedical Precinct. The partnership will focus on genomics based biomedical research and innovation in the […]
Initial project focus on uncovering metabolic signatures associated with neurodegenerative disease to provide deeper insight into mechanisms involved in Parkinson’s and its progression. February 11, 2020 — Olaris, a precision medicine company that is fundamentally changing how diseases are diagnosed and treated, today announced it has received a grant from The Michael J. Fox […]
Eden Prairie, Minn. – MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems, motion simulators and sensors, today announced a strategic alliance with Auburn University to accelerate additive manufacturing research and test development. Auburn University is home to the National Center for Additive Manufacturing Excellence (NCAME), which is a founding partner of the […]
DUBLIN, Ireland, and VIENNA, Austria: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Aelian Biotechnology (“Aelian”) today announced the signing of a license agreement granting Aelian access to ERS Genomics’ CRISPR/Cas9 patent portfolio, to support Aelian’s commercial functional genomic screening platform. Aelian […]
Freiburg, Germany | Boston, MA | Today, Eurofins GeneScan Technologies GmbH and UgenTec, Inc. announce the successful NF VALIDATION certification of five real-time PCR kits with the French Association of Standards (AFNOR). The submission and approval are part of an ongoing strategic partnership between Eurofins Genescan Technologies, a provider of RNA / DNA detection kits and UgenTec, a software company […]
DILIsym Services, a Simulations Plus company, in partnership with a large pharmaceutical company, is developing a QSP model focused on heart failure. QSP Modeling Project Targeted at Prevention of Heart Failure DILIsym Services Inc. (DSS), a Simulations Plus company (Nasdaq: SLP) and a leading provider of simulation and modeling software for pharmaceutical efficacy and safety, […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
